Is Measurement of Bilirubin a Valuable Predictive Tool to Detect Choledocholithiasis Before Cholecystectomy?
British Journal of Surgery · 16.05.2025 · 112 (Supplement_7)
DOI: 10.1093/bjs/znaf092.039 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 16.05.2025. Verfasst von J Zeindler und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Laparoscopic cholecystectomy is the treatment of choice for acute or chronic cholecystitis and symptomatic cholelithiasis. Preoperative measurement of Bilirubin is standard of care in most surgical clinics, while the predictive value of its measurement to detect choledocholithiasis is questionable.
Aims
We aimed to investigate the association of preoperative high bilirubin and detection of choledocholithiasis diagnosed with preoperative MRCP.
Methods
This is a retrospective multicentre cohort study including all patients receiving preoperative MRI-MRCP before undergoing elective or emergency cholecystectomy between 2010 and 2020. Preoperative blood parameters such as Bilirubin and MRCP reports were documented as well as postoperative outcome of the patients.
Results
3163 patients have undergone laparoscopic cholecystectomy between 2010 and 2020, of which 2568 have shown normal cholestatic parameters preoperatively. Of these patients, 684/2568 (27%) have been male and 1884/2568 (73%) female. The most frequent indications for laparoscopic cholecystectomy have been cholecystolithiasis in 72% (1845/2568) of cases, followed by cholecystitis in 18% (465/2568). The majority of patients (2267/2568, 88%) have received pMRCP, while only 301/2568 have not. We could detect silent CBD-stones in 6% of the patients with normal preoperative cholestatic parameters in MRCP (130/2267). Sensitivitiy of elevated bilirubin to detect CBD stones was only 33%.
Conclusion
Silent CBD stones are common and MRCP is a good diagnostic tool to detect them. Preoperative elevated bilirubin is not necessarily associated with CBD stones and patients should always receive MRCP. In normal lab tests preoperatively, the value of MRCP regarding cost-effectiveness remains debatable.
Zitieren
APA
Zeindler, J., Hess, G. F., Muenst, S., Kollmar, O., & Soysal, S. (2025). Is Measurement of Bilirubin a Valuable Predictive Tool to Detect Choledocholithiasis Before Cholecystectomy?. British Journal of Surgery, 112(Supplement_7). https://doi.org/10.1093/bjs/znaf092.039
Vancouver
Zeindler J, Hess GF, Muenst S, Kollmar O, Soysal S. Is Measurement of Bilirubin a Valuable Predictive Tool to Detect Choledocholithiasis Before Cholecystectomy?. British Journal of Surgery. 2025;112(Supplement_7). doi:10.1093/bjs/znaf092.039
BibTeX
@article{Zeindler2025,
author = {Zeindler, J and Hess, G F and Muenst, S and Kollmar, O and Soysal, S},
title = {Is Measurement of Bilirubin a Valuable Predictive Tool to Detect Choledocholithiasis Before Cholecystectomy?},
journal = {British Journal of Surgery},
year = {2025},
volume = {112},
number = {Supplement_7},
doi = {10.1093/bjs/znaf092.039}
}
EUVIMED